At ITOS, we extract DNA / RNA from individual cancer biopsy material and perform targeted sequencing to identify genetic perturbations in relevant targetable cancer related genes using the state-of-the-art NGS technology from Illumina. This information is then used to identify and link to specific treatment options based on the existing / ongoing scientific discoveries and clinical trials around the globe.
Gene panels tested:
- Detection of mutations in important cancer-related genes, including BRAF, KRAS and EGFR using validated gene panels.
- A detailed list of genes included in various gene panels can be obtained through contacting us directly.
- Hereditary gene panel to identify genetic predisposition of cancer
- At ITOS Oncology we also custom design gene / mutations panels to accommodate the needs of specific research projects.